Core Viewpoint - Guangnan Group (01203) reported a 12% year-on-year increase in revenue to HKD 6.081 billion for the six months ending June 30, 2025, with a 32% increase in profit attributable to shareholders to HKD 76.207 million [1] Financial Performance - Revenue for the food biotechnology segment reached HKD 5.019 billion, accounting for 83% of the group's total revenue, representing a year-on-year increase of HKD 589 million or 13% [1] - Profit from the food biotechnology segment (excluding share of profits from associates) was HKD 91.8 million, a decrease of 5% year-on-year [1] - The performance of the joint venture in live pig farming and sales improved significantly, with the group's share of profits from associates at HKD 14.55 million, recovering from a loss of HKD 18.77 million in the previous year [1] - Including the share of profits from associates, the profit for the food biotechnology segment was HKD 106 million, an increase of HKD 28.21 million or 36% year-on-year [1] Dividend Announcement - The company proposed an interim dividend of HKD 0.025 per share [1]
广南(集团)发布中期业绩，股东应占溢利7620.7万港元 同比增加32%